Myxoedema is a rare but high-yield topic for pharmacy students preparing for the OPRA exam. This guide covers its pathophysiology, clinical presentation, diagnostic markers, and treatment protocols, along with how it is distinguished from other causes of oedema and how it tends to appear in exam questions.
What Is Myxoedema?
Myxoedema is the most severe and advanced stage of hypothyroidism, resulting from insufficient production of thyroid hormones (T3 and T4). This slows metabolism and, if left untreated, can cause dysfunction across multiple organ systems.
What Is the Pathophysiology of Myxoedema?
-
Low levels of T3 and T4 lead to a decreased basal metabolic rate
-
Metabolic slowing reduces oxygen consumption and heat production, causing cold intolerance and weight gain
-
Accumulation of mucopolysaccharides causes water retention in the skin and subcutaneous tissues, leading to non-pitting oedema
-
Cardiovascular, neurological, gastrointestinal, and dermatological systems are all affected
OPRA Exam Tip: Remember that the non-pitting oedema in myxoedema is distinct from the oedema seen in nephrotic syndrome or heart failure, which is typically pitting.
What Are the Clinical Features of Myxoedema?
System: Skin & Hair
Signs & Symptoms: Dry, coarse skin, brittle hair, hair loss (especially lateral eyebrows)
Exam Point: Loss of the outer third of the eyebrows is a classic hypothyroidism sign
System: Face
Signs & Symptoms: Puffy face, periorbital swelling, macroglossia
Exam Point: Key feature in diagnosis
System: Cardiovascular
Signs & Symptoms: Bradycardia, pericardial effusion, low blood pressure
Exam Point: Watch for the risk of heart failure
System: Gastrointestinal
Signs & Symptoms: Constipation, bloating
Exam Point: Due to slowed gut motility
System: Central Nervous System
Signs & Symptoms: Slow reflexes, lethargy, depression, memory impairment; coma in severe cases
Exam Point: Red flag if coma develops (myxoedema coma)
System: Metabolic
Signs & Symptoms: Weight gain despite poor appetite, cold intolerance
Exam Point: Core topic of the exam
How Is Myxoedema Diagnosed?
-
Elevated TSH is the primary marker and most common indicator of hypothyroidism leading to myxoedema
-
Low free T4 levels confirm the diagnosis
-
Positive Anti-TPO antibodies indicate autoimmune hypothyroidism, known as Hashimoto's
-
Additional tests such as CBC (for anaemia), lipid profile (for hypercholesterolaemia), and ECG (for bradycardia) support the diagnostic picture
How Does Myxoedema Differ From Other Causes of Oedema?
Students often confuse the oedema of myxoedema with oedema from cardiac or renal causes. Here is a quick comparison:
Myxoedema
-
Type of oedema: Non-pitting
-
Underlying cause: Mucopolysaccharide accumulation from thyroid hormone deficiency
-
Associated findings: Bradycardia, cold intolerance, elevated TSH
Nephrotic Syndrome / Heart Failure
-
Type of oedema: Pitting
-
Underlying cause: Protein loss or fluid overload
-
Associated findings: Proteinuria (nephrotic) or raised JVP and breathlessness (heart failure)
The key distinction for exams: pressing on the skin leaves an indentation in pitting oedema, while myxoedema's non-pitting oedema does not indent on pressure.
What Is the Treatment and Management of Myxoedema?
Lifelong Thyroid Hormone Replacement
-
Levothyroxine (T4) is the gold standard
-
Start with a low dose in elderly or cardiac patients and titrate every 6 to 8 weeks based on TSH levels
Management of Myxoedema Coma (Medical Emergency)
-
IV levothyroxine or liothyronine
-
IV hydrocortisone, until adrenal insufficiency is ruled out
-
Supportive care including gentle rewarming, IV fluids, and treatment of the underlying cause such as infection or trauma
Monitoring
-
TSH is checked every 6 to 8 weeks until stable, then every 6 to 12 months
-
Pharmacists play a role in educating patients about lifelong therapy, drug-food interactions such as taking levothyroxine on an empty stomach, and adherence to follow-up tests
How Is Myxoedema Tested in OPRA Exam Questions?
Myxoedema questions in the OPRA exam typically test recognition of non-pitting oedema versus other causes, interpretation of thyroid function tests (high TSH, low T4), and identification of red flags that indicate progression to myxoedema coma. This kind of case-based recognition is the type of skill built through structured OPRA coaching, where clinical scenarios are broken down alongside the underlying pharmacology so that students can connect lab values to bedside presentation.
What Are Common Mistakes Students Make With Myxoedema Questions?
-
Confusing non-pitting oedema of myxoedema with pitting oedema of heart failure or nephrotic syndrome
-
Forgetting that TSH is elevated, not decreased, in primary hypothyroidism leading to myxoedema
-
Overlooking hydrocortisone administration in myxoedema coma management, since adrenal insufficiency must be ruled out first
-
Missing early red flags like bradycardia and hypothermia that can precede coma
Key Concepts Table for OPRA Exam
-
Definition: Most severe, advanced stage of untreated hypothyroidism
-
Cause: Accumulation of mucopolysaccharides in skin and soft tissue
-
Oedema Type: Non-pitting
-
Key Lab Findings : High TSH, low free T4, positive Anti-TPO (autoimmune cases)
-
Demographics: More common in middle-aged and older women
-
Emergency Complication: Myxoedema coma (confusion to unconsciousness, bradycardia, hypothermia, respiratory failure)
-
Treatment: Levothyroxine (lifelong); IV levothyroxine/liothyronine plus hydrocortisone in coma
-
Monitoring: TSH every 6-8 weeks until stable, then every 6-12 months
Conclusion
Myxoedema is a severe condition arising from untreated hypothyroidism, marked by non-pitting oedema and multi-organ involvement. For OPRA aspirants, the key points to retain are the biochemical picture (high TSH, low free T4), the classic clinical signs, and the management protocol for both routine hypothyroidism and the medical emergency of myxoedema coma. Early recognition, lifelong levothyroxine therapy, and consistent monitoring are what prevent progression to more serious complications, and these are the same clinical reasoning skills tested in case-based OPRA questions.
Key Takeaways
-
Myxoedema is the most severe and advanced stage of untreated hypothyroidism
-
It is caused by accumulation of mucopolysaccharides in the skin and soft tissues, leading to non-pitting oedema
-
Common in middle-aged and older adults, and more prevalent in women
-
Diagnosis relies on elevated TSH, low free T4, and positive Anti-TPO antibodies in autoimmune cases
-
If untreated, it can progress to myxoedema coma, a life-threatening emergency
-
Treatment involves lifelong thyroid hormone replacement with levothyroxine, and IV levothyroxine plus hydrocortisone in coma
Reference
https://www.ncbi.nlm.nih.gov/books/NBK545193/
https://pubmed.ncbi.nlm.nih.gov/7808091/
https://my.clevelandclinic.org/health/diseases/myxedema-coma